Condition

HER2-positive Gastric Cancer clinical trials and research

• 7Clinical trials
• 31Countries

Newest HER2-positive Gastric Cancer clinical trials

All recruiting trials (7)

• Fruquintinib with trastuzumab and XELOX for first-line treatment of HER2‑positive advanced stomach or GEJ cancer

  This trial will try fruquintinib together with trastuzumab and XELOX to see if it helps people with HER2‑positive advanced stomach or gastroesophageal junction cancer as their first treatment.

  Recruiting Phase 1/2 Henan Cancer Hospital · Zhengzhou, Henan · NCT07334431

• Evaluating the effectiveness and safety of Trastuzumab Deruxtecan in advanced HER2-positive gastric cancer in China

  This study is testing how well Trastuzumab Deruxtecan works and how safe it is for people in China with advanced HER2-positive stomach cancer who are already receiving this treatment.

  Recruiting at 34 sites Daiichi Sankyo · Beijing and 39 other locations · NCT06846996

• New treatment for HER2-positive gastric cancer using rilvegostomig and chemotherapy

  This study is testing a new treatment combining rilvegostomig with chemotherapy for people with HER2-positive gastric cancer to see if it works better than current standard treatments.

  Recruiting at 253 sites Phase 3 AstraZeneca · Anchorage, Alaska and 303 other locations · NCT06764875

• Combination treatment for advanced HER2-positive gastric cancer

  This study is testing a new combination of treatments for people with advanced HER2-positive gastric cancer to see if it works better than the standard chemotherapy options.

  Recruiting at 16 sites Phase 2 Qilu Hospital of Shandong University · Zhengzhou, Henan and 19 other locations · NCT06730373

• Combination therapy of Disitamab Vedotin and Trastuzumab for HER2 positive gastric cancer

  This study is testing a new combination of two drugs, Disitamab Vedotin and Trastuzumab, to see if it can help people with advanced HER2 positive gastric cancer who haven't responded to other treatments.

  Recruiting Phase 1/2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06572319

• Treatment for HER2-positive gastric and gastroesophageal junction cancer

  This study is testing a new treatment combining HLX22, trastuzumab, and chemotherapy to see if it helps people with advanced HER2-positive stomach cancer feel better compared to standard treatment.

  Recruiting at 206 sites Phase 3 Shanghai Henlius Biotech · Anaheim, California and 207 other locations · NCT06532006

• Treatment for HER2-positive gastric cancer after surgery

  This study is testing if a new combination treatment can help people with HER2-positive gastric cancer feel better after their surgery if they still have some cancer left.

  Recruiting Phase 2 Gruppo Oncologico del Nord-Ovest · Milan · NCT06253650

Related topics

Quick answers

How many HER2-positive Gastric Cancer clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 31 countries. The most sites are in China (6 trials), Italy (3 trials), Argentina (2 trials), Australia (2 trials), Brazil (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →